Clinical trial · Observational
Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective Study
Comparison of CE-MRI and CEUS for Measuring Tumor Size of HCC
NCT06437457CI-TRIAL-00077641completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Knowing the tumor size before operation is of great significance to the choice of treatment methods of surgeons and the prognosis of patients. In this study, two commonly used imaging methods( CE-MRI/CEUS) were selected to measure and compare the tumor size before operation, in order to determine which measurement method is more accurate.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HCC - Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ceus | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- CEUS
- description
- The patients who underwent CEUS before liver resection
- interventionNames
- Radiation: ceus
- label
- CE-MRI
- description
- The patients who underwent CE-MRI before liver resection
- interventionNames
- Radiation: ceus
Primary outcomes (1)
- measure
- measuring HCC diameter
- timeFrame
- Jaunary 2019 - May 2024
- description
- the performance of Gd-EOB-DTPA-enhanced MRI (CE-MRI) and Contrast-enhanced Ultrasound (CEUS) in measuring tumor size of solitary hepatocellular carcinoma (HCC) ≤5cm.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. had no anti-HCC therapy before imaging examinations. 2. at least had one examination of Gd-EOB-DTPA-enhanced MRI and CEUS 2 weeks before surgery and confirmed as one single HCC. 3. If the patient had both imaging tests, the time interval between two examinations was less than 1 weeks. 4. both radiological and pathological results recorded the maximum tumor diameter. Exclusion Criteria: 1. had anti-HCC therapy before imaging examinations. 2. had no examination of Gd-EOB-DTPA-enhanced MRI or CEUS 2 weeks before surgery . 3. had no radiological or pathological results recorded the maximum tumor diameter.
References
Publications (0)
Data not yet available
No reference posted for this study.